Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis.
Amyloidosis
Axonal degeneration
Polyneuropathy
Pompe disease
Transthyretin
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
22
09
2020
accepted:
09
11
2020
pubmed:
15
11
2020
medline:
11
5
2021
entrez:
14
11
2020
Statut:
ppublish
Résumé
Hereditary transthyretin amyloidosis with polyneuropathy (hATTRPN) is an autosomal dominant multi-organ disorder manifesting in the third to fifth decade with the key clinical features of distal and painful sensory loss of the lower limbs and autonomic dysregulation. Motor neuropathy and cardiomyopathy evolve in the course of the disease. Pompe disease is an autosomal recessive disease leading to decreased levels of lysosomal enzyme acid α-glucosidase and proximal muscle weakness. We report the clinical features and diagnostic workup in the rare case of a patient with ATTR amyloidosis and late-onset Pompe disease, both genetically confirmed. We performed a detailed clinical assessment, exome sequencing, and biochemical measurements. The patient presented with a distal, painful hypaesthesia of both legs, a cardiomyopathy, and a muscle weakness in the form of a girdle-type pattern of the arms and legs at the beginning and a spreading to distal muscle groups in the course of disease. This study highlights the importance of searching for co-occurrence of rare monogenetic neuromuscular diseases, especially in cases in which all clinical features can be readily explained by a single gene defect.
Identifiants
pubmed: 33188503
doi: 10.1007/s10072-020-04896-3
pii: 10.1007/s10072-020-04896-3
pmc: PMC7955998
doi:
Substances chimiques
Prealbumin
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1523-1525Références
Abeykoon JP, Duma N, Tracy JA et al (2018) Pompe disease could mimic exam findings of amyloidosis: two rare diagnoses bona fide. Case Rep Hematol 2018:9615834
pubmed: 30510819
pmcid: 6230410
Adams D, Ando Y, Beirao JM et al (2020) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. https://doi.org/10.1007/s00415-019-09688-0
Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, Kissel JT, of the AANEM CONSENSUS COMMITTEE ON LATE-ONSET POMPE DISEASE (2012) Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 45:319–333
doi: 10.1002/mus.22329
Dohrn MF, Rocken C, De Bleecker JL et al (2013) Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J Neurol 260:3093–3108
doi: 10.1007/s00415-013-7124-7
Loscher WN, Huemer M, Stulnig TM et al (2018) Pompe disease in Austria: clinical, genetic and epidemiological aspects. J Neurol 265:159–164
doi: 10.1007/s00415-017-8686-6
Nowak A, Mechtler T, Kasper DC, Desnick RJ (2017) Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and later-onset Fabry disease. Mol Genet Metab 121:320–324
doi: 10.1016/j.ymgme.2017.06.006
Paganoni S, Amato A (2013) Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am 24:193–207
doi: 10.1016/j.pmr.2012.08.017